Comparison of the effect of the combination of letrozole and clomiphene in stimulating ovulation in intrauterine insemination cycles with letrozole alone: ??A clinical trial study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240514061800N10

Enrollment

160

Registered

2026-02-24

Start date

2026-04-21

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine insemination. Normal Pregnancy

Interventions

Intervention 1: Intervention group: In this group, letrozole is given at a dose of 2.5-5 milligrams (made by the same company) daily from the third to the seventh day of the cycle. Intervention 2: Int

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women 40 years old or younger Infertile couples with intermediate male factor Couples with unexplained infertility

Exclusion criteria

Exclusion criteria: Women over 40 years old The presence of abnormal hormone tests Severely abnormal spermogram The presence of an abnormal HSG, either in terms of the uterine cavity or in terms of blockage of the fallopian tubes

Design outcomes

Primary

Measure	Time frame
Measuring ßHCG levels. Timepoint: Two weeks after the intervention. Method of measurement: Using the laboratory method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTayebe Esfidani

Shahid Beheshti University of Medical Sciences

Esfidani.tayebeh@gmail.com+98 21 23871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026